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Abstract: Lysenin is a pore-forming toxin of the aerolysin family, which is derived from coelomic
fluid of the earthworm Eisenia fetida. Upon binding to sphingomyelin (SM)-containing membranes,
lysenin undergoes a series of structural changes promoting the conversion of water-soluble monomers
into oligomers, leading to its insertion into the membrane and the formation of a lytic β-barrel pore.
The soluble monomer and transmembrane pore structures were recently described, but the underlying
structural details of oligomerization remain unclear. To investigate the molecular mechanisms
controlling the conformational rearrangements accompanying pore formation, we compared
the hydrogen–deuterium exchange pattern between lyseninWT and its mutant lyseninV88C/Y131C.
This mutation arrests lysenin oligomers in the prepore state at the membrane surface and does not
affect the structural dynamics of the water-soluble form of lysenin. In contrast, membrane-bound
lyseninV88C/Y131C exhibited increased structural stabilization, especially within the twisted β-sheet
of the N-terminal domain. We demonstrated that the structural stabilization of the lysenin prepore
started at the site of lysenin’s initial interaction with the lipid membrane and was transmitted
to the twisted β-sheet of the N-terminal domain, and that lyseninV88C/Y131C was arrested in this
conformation. In lyseninWT, stabilization of these regions drove the conformational changes necessary
for pore formation.
Keywords: hydrogen-deuterium exchange; lysenin; pore formation; structure; toxin
Key Contribution: Lytic pore formation is accompanied by progressing stabilization of the lysenin
structure. Structural stabilization propagates from the membrane-binding site in the C-terminal
domain to the collar region of N-terminal domain at the prepore step and is required for pore formation.
1. Introduction
Lysenin is a toxic protein produced by Eisenia fetida that plays important roles in this
earthworm’s innate immunity and defense strategies against parasites [1,2]. Lysenin belongs to
the family of aerolysin-like pore-forming proteins (aβ-PFPs), of which the founding member
(aerolysin) is a well-studied toxin produced by the pathogenic bacterium Aeromonas hydrophila.
The aβ-PFP family includes numerous toxins present throughout all kingdoms of life: bacteria,
fungi, plants, and animals [3–9]. While many aβ-PFPs family members produced by pathogenic
bacteria (e.g., Aeromonas, Clostridium, and Bacillus) act as virulence factors in food poisoning and
infections, aβ-PFP family members produced by eukaryotes serve in defense against pathogens or
parasites [6,10,11]. The amino acid sequences of all aerolysin-like proteins exhibit low homology
Toxins 2019, 11, 462; doi:10.3390/toxins11080462 www.mdpi.com/journal/toxins
Toxins 2019, 11, 462 2 of 24
but share a similar monomeric architecture, particularly a conserved N-terminal domain involved in
β-barrel pore formation.
Like most pore-forming toxins, lysenin is produced and secreted as a soluble monomer.
Crystallographic analyses reveal that lysenin comprises two main structural domains: an N-terminus
pore-forming module (PFM) at amino acid position 1–160, which contains a SM-binding site and the
membrane insertion loop (position 34–107), and the C-terminalβ-trefoil receptor-binding domain (RBD)
at amino acid position 161–297, which is responsible for initial binding with the lipid membrane [9]
(Figure 1A). The crystal structure of the monomeric form of lysenin bound to SM reveals that toxin
binding requires both the hydrophilic (phosphocholine head group; POC) and hydrophobic (acyl chain
tail) lipid portions [9] (Figure 1B). Previous crystallographic studies and analyses of the binding of
deletion mutants have revealed that lysenin interacts with membranes in a two-stage process [9,12].
First, a patch of positively charged amino acids in the C-terminal domain attracts toxin to the membrane
surface and allows the initial binding of the C-terminal domain to the POC of SM via both a hydrogen
bond network (including S227, Y233, and Y282) and a salt bridge interaction (K185). Second, two
critical tyrosine residues (Y24 and Y26) located in the PFM of the N-terminal domain bind the acyl
chain of SM via ring stacking–like interactions [9]. Detailed analysis of the crystal structure of the
lysenin/SM complex has revealed that other PFM residues, including K21, Q117, and E128, also interact
with the SM head group, creating an additional hydrophilic binding site. The multivalent SM binding
site at the C-terminal domain facilitates the interaction of lysenin with clustered SM organized into the
SM-rich domains of the plasma membrane, thus increasing the probability of a monomer-monomer
encounter [13–17]. In turn, this enables lysenin monomers to create oligomeric structures (prepores) on
the lipid membrane surface, which undergo a large conformational rearrangement, leading to insertion
into the lipid membrane and pore formation.
Blue native electrophoresis has revealed that stable oligomer formation in SM-containing
membranes correlates with lysenin self-assembly into trimers that act as the functional unit of
the protein bound to SM [13,14]. Lysenin oligomerization, but not binding, is facilitated by cholesterol
presence, which increases the fluidity of SM-containing membranes and promotes separation of the
SM-rich liquid-ordered phase [14,17–19]. Previous studies based on electron microscopy, atomic force
microscopy (AFM), and two-dimensional electron crystallography have revealed that lysenin oligomers
assemble into a hexagonal close-packed (hcp) structure with an external diameter of ~10–11 nm and an
inner pore of ~6 nm [9,16,19]. AFM measurements of hcp assemblies of lysenin on a SM-containing
bilayer have elucidated the presence of two oligomer populations with different heights—2.6 and 5 nm.
Investigations of the cholesterol-dependent cytolysin perfringolysin O (PFO) have also revealed the
presence of two distinct oligomer populations, while the lower-height oligomers (2.6 nm) correspond to
membrane-inserted oligomers (pores), and the taller oligomers (5 nm) represent the prepore state [20,21].
The height of the putative lysenin’s prepore corresponds to the height of the water-soluble lysenin
monomer, suggesting that lysenin protomers in the prepore state do not undergo radical structural
rearrangements that change the protein’s orientation to the membrane surface.
The conversion from the prepore to the pore state entails critical conformational reorganizations of
lysenin structure, which only involve the N-terminal domain of lysenin (Figure 1C). It has been suggested
that the contacts between neighboring monomers in the prepore state, and the geometrically and
energetically conductive intramolecular interactions between β-strands, are triggers for displacement
of the insertion loop covering the region from amino acid residues 44–67 (the tongue). Insertion loop
movement leads to breakage of the hydrogen bonds between the β-strand pairs β3 (pos. 38–44)
and β9 (pos. 125–128), and β5 (pos. 68–81) and β11 (pos. 147–156), as well as displacement of
the strands β5 and β6 (pos. 84–90). This leads to insertion loop unfolding, bringing together the
parallel-oriented strands β2 (pos. 12–27) and β10 (pos.129–138) of adjacent monomers, and tilting the
twisted β-sheet containing the strands β2, β8 (pos. 111–121), β10, and β11 by a 45-degree angle relative
to the receptor-binding domain. The reorganization of the N-terminal domain within the strands β4
(pos. 54–57), β5, and β6 (pos. 84–90), as well as a single α310 helix (pos. 91–96) of each protomer, forces
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the extending strands β3 and β7 (pos. 99–103) to reassemble into tilted and twisted β-hairpins (amino
acid residues 34–107). Finally, nine β-hairpins curve nearly 270◦ during incorporation into the lipid
membrane, constructing a final β-barrel structure. Overall, the lysenin pore exhibits a mushroom-like
architecture with the β-barrel creating a central stem passing through the lipid membrane, and the
mushroom cap formed by the C-terminal receptor-binding domains (bottom part of the cap) and
β-strands (β2, β8, β10, and β11) originating from the N-terminal domains (upper part of the cap,
collar) (Figure 1D).
The transition of a toxin from a water-soluble form to a membrane-anchored form requires
dramatic structural reorganization. Although recent studies have elucidated several aspects of pore
formation by lysenin [8,22], the structural characterization of intermediate steps of the pore-formation
pathway remains incomplete. To gain insight into the structural dynamics of lysenin in the pre-pore
state, and to characterize structural changes accompanying its insertion into the lipid membrane, we
applied hydrogen–deuterium exchange mass spectrometry (HDX-MS).
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Figure 1. Crystal structure and structural rearrangement of the monomeric form of lysenin upon 
membrane binding. (A,B,C) Overall crystallographic structures of the water-soluble monomer of 
lysenin (A) and monomeric lysenin bound to sphingomyelin (SM) (B) (PDB ID: 3ZXG) as obtained by 
de Colibus [9], and a protomer from the lysenin pore (PDB ID: 5EC5) [22] (C). (D) Mushroom-like 
structure of a lysenin pore. Turquoise indicates the C-terminal domain (RBD, receptor-binding 
domain); yellow indicates the structurally intact region of the N-terminal domain; red indicates the 
insertion loop of the N-terminal domain. SM is represented as ball model and colored in blue. 
HDX is a complex process whose kinetics depends on both protein dynamics and intrinsic 
amide hydrogen exchange rates. Two factors may affect the hydrogen–deuterium exchange: solvent 
accessibility and H-bonding. However, water molecules penetrate protein structures quite 
efficiently. Therefore, it is believed the main factor protecting from exchange is the involvement of 
amide in H-bonding, i.e., the stability of local secondary structure elements, while solvent 
Figure 1. Crystal structure and structural rearrangement of the monomeric form of lysenin upon
membrane binding. (A–C) Overall crystallographic structures of the water-soluble monomer of lysenin
(A) and monomeric lysenin bound to sphingomyelin (SM) (B) (PDB ID: 3ZXG) as obtained by de
Colibus [9], and a protomer from the lysenin pore (PDB ID: 5EC5) [22] (C). (D) Mushroom-like structure
of a lysenin pore. Turquoise indicates the C-terminal domain (RBD, receptor-binding domain); yellow
indicates the structurally intact region of the N-terminal domain; red indicates the insertion loop of the
N-terminal domain. SM is represented as ball model and colored in blue.
HDX is a complex process whose kinetics depends on both protein dynamics and intrinsic
amide hydrogen exchange rates. Two factors may affect the hydrogen–deuterium exchange: solvent
accessibility and H-bonding. However, water molecules penetrate protein structures quite efficiently.
Therefore, it is believed the main factor protecting from exchange is the involvement of amide in
H-bonding, i.e., the stability of local secondary structure elements, while solvent accessibility has
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minor influence [23]. Generally, due to the fact that protection against hydrogen–deuterium exchange
may be best correlated with the “order” in a given region of protein, we interpret the results in terms of
structural stability in a given region. Therefore, this method provides useful information regarding the
dynamics of structural elements of pore-forming proteins, both in solution and upon interaction with a
lipid membrane and enables investigation of the conformational changes accompanying transitions
between protein states with high reproducibility and precision [24–26].
Previous studies have indicated that introducing the double-cysteine mutation V88C/Y131C in
lysenin enables creation of a disulfide bond that locks together the β6 and β10 strands and prevents
β6 displacement from the rest of the toxin molecule. Consequently, this mutation abolishes lytic
activity while preserving oligomer formation [22], such that lyseninV88C/Y131C, is an ideal candidate for
characterizing the structural dynamics of lysenin oligomers arrested in the pre-pore state. To obtain
structural information regarding the mechanism of lysenin oligomerization, we compared the patterns
of the exchange of amide protons in lyseninWT with those in lyseninV88C/Y131C, both in aqueous solution
and upon binding to SM-containing membranes. This approach enabled mapping of the regions in the
lysenin molecule where the kinetics of hydrogen–deuterium exchange are substantially altered after
interaction with the model lipid membranes.
Our present results indicate the structural dynamics of the lysenin regions involved in the two
stages of pore formation: transition of the water-soluble lysenin monomer into the ring-shaped
oligomer and its conversion into the β-barrel membrane-inserted pore. We demonstrated that the
double-cysteine mutation promoted stabilization of the majority of lysenin regions upon binding the
lipid membrane. Moreover, the structural stabilization of lyseninV88C/Y131C was more pronounced in
the regions that form the N-terminal cap domain in the lysenin pore state, which have not previously
been considered to be crucial in the oligomerization and pore formation processes. These findings
suggest that increased stability in these regions supports the maintenance of lysenin in the correct
orientation relative to the membrane and adjacent monomers in the pre-pore complex and forces
further structural rearrangements that drive pore formation.
2. Results
2.1. LyseninV88C/Y181C Binding to SM-Containing Membranes
The first step in transmembrane pore formation is the binding of lysenin to SM of the lipid bilayer.
The crystal structure of lysenin bound to SM reveals that two sites are responsible for SM binding: the
positively-charged patch on the C-terminal domain and the tyrosine residues (Y24 and Y26) in the β2
strand of the PFM in the N-terminal domain [9]. The cysteine mutations V88C and Y131C are introduced
in the β6 and β10 strands, outside of the region responsible for the interaction between lysenin and
SM. However, studies of perfringolysin O (PFO), a member of the cholesterol-dependent cytolysin
family of pore-forming toxins, have shown that modification within the pore-forming domain alters
the PFO’s interaction with the lipid membrane, indicating structural and functional coupling between
two distant and spatially separated domains of the toxin [27]. LyseninV88C/Y131C exhibits disabled lytic
activity [22], but its interaction with SM in the membrane has not previously been characterized. In the
present study, a lipid overlay assay revealed that both lyseninWT and lyseninV88C/Y131C selectively
recognized and bound SM in a dose-dependent manner, starting from 5 pmol lipid, and with high
specificity (not recognizing cholesterol or phospholipids, such as DOPC or DPPC), indicating that
lyseninV88C/Y181C retained the selectivity for SM binding that was observed in lyseninWT (Figure 2A).
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We also demonstrated the ability of lyseninV88C/Y181C to bind to SM based on surface plasmon
resonance measurements using liposomes composed of SM mixed with DOPC and cholesterol (molar
ratio 1:2:1). Previous studies show that, when oxidized, the double-cysteine mutation V88C/Y131C
retains disulfide-trapped lysenin oligomers on the membrane surface upon binding to a SM-containing
bilayer. However, when a reducing agent (e.g., DTT) breaks the disulfide bond between these cysteine
residues, lysenin oligomers become inserted into the lipid bilayer [22].
Sensogram analysis revealed that lyseninWT reached a plateau value of ~6900 RU after a dissociation
time of 300 s. In comparison, lyseninV88C/Y181C displayed a stronger tendency for dissociation, reaching
5300 RU at this time-point (Figure 2B). In contrast, the dissociation curves of lyseninV88C/Y181C in the
presence of 10 mM DTT were comparable to those of lyseninWT, reaching a value of ~6800 RU after a
dissociation time of 300 s (Figure 2B).
To further analyze the interactions of lyseninWT and lyseninV88C/Y131C ith the lipid membranes,
we measured changes in the surface pressure of the lipid monolayer. The surface-active properties of
lysenin molecules were initially characterized by measuring spontaneous adsorption of the proteins
at the argon–water interface. Injection of both lyseninWT and lyseninV88C/Y131C into the aqueous
sub-phase prompted a two-phase increase of surface pressure in a dose-dependent manner (Figure S1).
Adsorption kinetics analysis showed that, when using lower protein concentrations of 0.5–2 nM,
the rates of surface pressure changes were higher with lyseninV88C/Y131C than with lyseninWT. However,
at higher protein concentrations, both proteins exhibited similar kinetics of surface pressure changes,
reaching surface pressure saturation (16 mN/m) at a concentration of 40 nM (Figure S1).
To initiate surface pressure changes in mixed lipid monomolecular layers spread at the argon–water
interface, we injected 40 nM lyseninWT and lyseninV88C/Y131C into the buffer sub-phase. For the
monolayer composed of SM/DOPC/cholesterol, we found that the surface pressure changes (∆pi)
induced by lyseninWT reached 13 mN/m, while those induced by lyseninV88C/Y131C amounted to
8 mN/m (Figure 3A). Addition of 10 mM DTT increased the kinetics of surface pressure evoked by
lyseninV88C/Y131C to the level observed with lyseninWT, indicating that cysteine resid e reduction
allowed incorporation of lyseninV88C/Y131C in a similar manner as lyseninWT. Negligible changes of the
surface pressure were found for DOP /cholesterol monolayers (Figure 3A). Measurement of intrinsic
tryptophan fluorescence confirmed that upon binding to SM-containing liposomes under reduced
co ditions, lyseninV88C/Y131C incorporated into the lipid membrane similarly to lyseninWT. In contrast,
in the oxidize state, bindi g to liposomes left the tryptophan residues of lyseninV88C/Y131C in a more
hydrophilic environment (Figure 3B).
Toxins 2019, 11, 462 6 of 24
Toxins 2019, 11, x FOR PEER REVIEW 6 of 23 
 
 
Figure 3. Effect of V88C/Y131C mutation on lysenin’s interaction with SM-containing layers. (A) 
Surface pressure changes caused by penetration of lyseninWT (solid, black line), lyseninV88C/Y131C with 
10 mM DTT (solid, red line), or lyseninV88C/Y131C without 10 mM DTT (solid, blue line) into a lipid 
monolayer containing SM/DOPC/cholesterol or DOPC/cholesterol (dashed, black line; lyseninWT), 
(dashed, blue line; lyseninV88C/Y131C). Plots represent one of three experiments. (B) Tryptophan 
emission spectra of lyseninWT (solid, black line), lyseninV88C/Y131C with 10 mM DTT (solid, red line), or 
lyseninV88C/Y131C without 10 mM DTT (solid, blue line) bound to liposomes composed of 
SM/DOPC/cholesterol or in aqueous solution (dashed, black line; lyseninWT) (dashed, blue line; 
lyseninV88C/Y131C). Plots are representative of three independent measurements. 
2.2. Effect of V88C/Y181C Mutation on Oligomerization and Pore-Forming Activity 
The interaction of lysenin with an SM-containing membrane causes the lysenin molecules to 
self-assemble, forming highly stable oligomers [18]. Electron microscopy analysis revealed that upon 
binding to SM-containing liposomes, both lyseninWT and lyseninV88C/Y131C formed well-organized 
oligomeric structures distributed in a honeycomb-like pattern, regardless of whether a reducing 
agent was present (Figure 4A). However, in the absence of DTT, lyseninV88C/Y131C clearly created less 
contrasting oligomeric structures. These findings may suggest that lyseninV88C/Y131C and lyseninWT 
differ in their orientation relative to the SM-containing membrane or oligomeric form [28]. 
Figure 3. Effect of V88C/Y131C mutation on lysenin’s interaction with SM-containing l yers. (A) Surface
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DTT (solid, red line) or lyseninV88C/Y131C without 10 mM DTT (solid, blue line) into a lipid monolayer
containing SM/DOPC/cholesterol or DOPC/cholesterol (dashed, black line; lyseninWT), (dashed, blue
line; lyseninV88C/Y131C). Plots represent one of thre xperiments. (B) Tryptophan emission spectra of
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without 10 mM DTT (solid, blue line) bound to liposomes composed f SM/DOPC/cholesterol or
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representative of three independent measurements.
2.2. Effect of V88C/Y181C Mutation on Oligomerization and Pore-Forming Activity
The interaction of lysenin with an SM-containing membrane causes the lysenin molecules to
self-assemble, forming highly stable oligomers [18]. Electron microscopy analysis revealed that upon
binding to SM-containing liposomes, both lyseninWT and lyseninV88C/Y131C formed well-organized
oligomeric structures distributed in a honeycomb-like pattern, regardless of whether a reducing
agent was present (Figure 4A). However, in the absence of DTT, lyseninV88C/Y131C clearly created less
contrasting oligomeric structures. These findings may suggest that lyseninV88C/Y131C and lyseninWT
differ in their orientation relative to the SM-containing membrane or oligomeric form [28].
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Figure 4. Oligomerization of lyseninWT and lyseninV88C/Y131C upon binding to SM-containing liposomes.
(A) Electron microscopy images of SM-containing membranes with bound oligomers of lyseninWT
and lyseninV88C/Y131C with or without 10 mM DTT. Oligomers were formed after incubation of 7 µM
lysenin with LVs composed of SM/DOPC/cholesterol for 30 min at 20 ◦C. Samples of oligomers bound
to liposomes were transferred onto electro microscopy grids, and negatively stained. Scale bars,
200 nm. (B) UVs composed of M/DOPC/cholesterol were incubated w th 1 µM lyseninWT or
lyseninV88C/Y131C (with or without 10 mM DTT) for 30 min at 20 ◦C or 37 ◦C. Pelleted liposomes were
subjected to SDS-PAGE (4–20% gradient) and analyzed for the presence of lysenin monomers and
oligomers. Molecular weight standards are shown on the left. (C) Protection of lysenin against trypsin
digestion after binding to liposomes. Liposomes were incubated for 30 min at 37 ◦C with lyseninWT
or lyseninV88C/Y131C (with or without 10 mM DTT), and then treated with trypsin (marked as +) or
not (marked as −). Protease digestion products were analyzed by 4–20% gradient SDS-PAGE with
Coomassie Brilliant Blue staining.
Additional studies perf rme wi h lyseninWT confirmed that this protein efficiently formed
SDS-stable oligomers up n binding to liposomes composed of SM/DOPC/choles erol at both 20 ◦C and
37 ◦C. The double-cysteine mutation V88C/Y131C disrupted the formation of SDS-stable oligomers,
which was particularly evident when lyseninV88C/Y131C was incubated with SM/DOPC/cholesterol
liposomes at 20 ◦C. Under these conditions, the vast majority of lyseninV88C/Y131C was observed in the
monomer form, with only minute amounts of SDS-resistant oligomers detected (Figure 4B). However,
analysis of oligomerization under native conditions indicated that, upon binding to SM-containing
membranes, lyseninV88C/Y131C forms oligomeric assemblies comparable to lyseninWT (Figure S2).
Reduction of disulfide bonds using 10 mM DTT restored the stability of lyseninV88C/Y131C oligomeric
complexes, which was particularly evident when SM-containing liposomes were incubated at 37 ◦C
(Figure 4B). Further analysis of oligomer stability showed that lyseninV88C/Y131C that bound to liposomes
at 37 ◦C was more susceptible to trypsin digestion compared to lyseninWT (Figure 4C). Addition of
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10 mM DTT to the lyseninV88C/Y131C/liposome mixture increased the protection of lyseninV88C/Y131C
oligomers from proteolytic digestion (Figure 4C), to equal that observed with lyseninWT. These results
suggested that oligomers of lyseninV88C/Y131C formed under oxidized condition differed from lyseninWT
oligomers with regards to structural stability and the degree of incorporation into the lipid membrane.
The ability of lysenin to form SDS-resistant oligomers correlates with its pore-forming activity
that leads to hemolysis of erythrocytes. To estimate the relative lytic activities of lyseninV88C/Y131C,
we performed fluorometric measurements of carboxyfluorescein release from lipid vesicles and a
hemolytic assay. In agreement with previous findings [17], lyseninWT dose-dependently increased
lipid membrane permeability, while lyseninV88C/Y131C did not induce carboxyfluorescein release from
liposomes (Figure 5A).
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Figure 5. Effects of V88C/Y131C mutation on lysenin pore formation and hemolytic activity.
(A) Lysenin’s pore-forming activity was determined by fluorometric measurement of carboxyfluorescein
release from SUVs composed of SM/DOPC/cholesterol after a 30-min incubation at 37 ◦C with different
concentrations of lyseninWT (black bars), lyseninV88C/Y131C (blue bars) and lyseninV88C/Y131C with
10 mM DTT (red bars). The results were expressed as a percentage of the total carboxyfluorescein
released from SUVs following treatment with 0.1% Triton X-100. (B) Hemolytic activity of lyseninWT
(black line), lyseninV88C/Y131C (blue line) and lyseninV88C/Y131C with 10 mM DTT (red line). RBCs were
incubated for 45 min with indicated concentrations of the recombinant proteins at 37 ◦C (soiled lines)
and 20 ◦C (dashed lines). The amount of released hemoglobin was expressed as a percentage of the
total amount of hemoglobin released by osmotic lysis of RBCs. The results represent the mean ± SD of
three xperiments.
In the presence of 10 mM DTT, the pore-f ming activity of lyseninV88C/Y131C was restored to a level
near that observed f r lys ninWT, reaching almost 100% carboxyfluorescein lease aft r incubation
with 500 nM of protein at 37 ◦C (Figure 5A). Accordingly, the double-cysteine mutation also markedly
decreased the hemolytic activity of lysenin for concentrations up to 500 nM, at both 20 ◦C and 37 ◦C
(Figure 5B). In the presence of a reducing agent (10 mM DTT), the hemolytic activity of lyseninV88C/Y131C
was completely restored at both incubation temperatures (Figure 5B), reaching HA50 at about 25 µM
and 60 µM with incubation at 20 ◦C and 37 ◦C, respectively, confirming earlier data [22]. As we
expected, the presence of DTT did not change the hemolytic activity of lyseninWT. We also observed
that the presence of reducing agent restored the lytic activity of lyseninV88C/Y131C for HEK293 cells that
have lower SM content in the plasma membrane than erythrocytes. Total calcein release from HEK293
cells incubated with lyseninWT was observ d at a concentration of 500 nM after a one-hour incubation
at 37 ◦C, while lys ninV88C/Y131C supplemented with 10 mM DTT induced ~90% of that calcein eﬄux
(Figure S3).
2.3. Effects of the V88C/Y181C Mutation on Lysenin’s Structure in its Soluble Form
To gain insight into the structural changes accompanying lysenin’s interaction with the membrane,
we performed HDX-MS, which can distinguish unstructured (flexible, destabilized) from highly
structured (stabilized) regions of a protein based on differences in the exchange kinetics of amide
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protons. We applied HDX-MS to obtain information regarding the accessibility of amide protons for
deuterium uptake in different regions of lyseninWT and lyseninV88C/Y131C, both in solution and bound
to the lipid membrane.
Pepsin digestion allowed to obtain high sequence coverage (over 85%) for lyseninWT and
lyseninV88C/Y131C at different conditions, with overlapping peptides in multiple regions (Figure S4).
To perform the hydrogen–deuterium exchange reaction of proteins in aqueous solution, samples were
incubated with D2O at 20 ◦C for different times (10 s, 1 min, 5 min, 20 min, 2 h, or 24 h). The results
obtained for 10 seconds of the hydrogen–deuterium exchange reaction revealed an intertwined
pattern of protected (structured) and unprotected (unstructured) regions along the lysenin sequence
(Figure 6A).
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Figure 6. Hydrogen–deuterium exchange patterns for lyseninWT and lyseninV88C/Y131C in aqueous
solution. (A,B) Plots show the hydrogen–deuterium exchange pattern of amide protons (y axis) for
lyseninWT (black), lyseninV88C/Y131C without DTT (blue), and lyseninV88C/Y131C with 10 mM DTT (red)
in aqueous solution (top panels). Samples were incubated with deuterium buffer for 10 s (A) or
20 min (B) Peptides are represented with horizontal bars indicating their lengths and positions in the
lysenin amino acid sequence (horizontal axis). Regions organized into β strands and the 3/10 helix
of the N-terminal nd C-terminal d ains re indicated at the top of the graph. Y-axis error bars
indicate standard deviati ns calculated fro at least three independent experiments. The HDX data
are rep esented with color-coding on schematic repres ntations of the monomeric crystallographic
structure of lysenin (bottom panels). Color coding: red regions: 80–100% deuteration; yellow regions:
40–80% deuteration; blue regions: 0–40% deuteration; grey regions: fragments not covered by the
data. (C,D) Subtraction plots of the HDX patterns were generated to better visualize changes in the
exchange patterns of lyseninV88C/Y131C vs. lyseninWT in aqueous solution. Data were obtained by
subtracting the fraction of hydrogen–deuterium exchange of lyseninWT from that of lyseninV88C/Y131C
without DTT (blue) or lyseninV88C/Y131C with 10 mM DTT (red) after 10 s (C) or 20 min (D) deuteration
in aqueous solution. Positive and negative values, respectively, indicate regions that were destabilized
and stabilized in the lysenin mutant. Error bars were calculated as the square root of the sum of
variances of the subtracted numbers.
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When analyzing the structural dynamics of lyseninWT, we found that both the N-terminal and
C-terminal domains included highly dynamic regions (deuteration above 50%) and strongly stiffened
regions (deuteration lower than 20%) (Figure 6A; top panel, black). The regions exhibiting the fastest
exchange, with visible deuteration after 10 seconds, were detected for peptides encompassing strands
β3 and β10–β11 in the N-terminal domain, and amino acid positions 180–197 and 203–209 in the
C-terminal domain (Figure 6A). The hydrogen–deuterium exchange reaction for 20 min exhibited a
relatively high degree of the dynamics of soluble lyseninWT, indicating deuteration levels of >50%
along the majority of the lysenin sequence (Figure 6B; top panel, black). Few peptides exhibited strong
protection against the exchange reaction, with only three regions showing <30% deuteration. The most
stabilized peptides spanned amino acid positions 70–76 (strand β5) in the N-terminal domain, and two
peptides in the C-terminal domain at positions 198–202 and 266–272 (Figure 6B; top panel, black).
The presence of a set of relatively stable regions allowed precise organization of the flexible structure
of lysenin in space.
We also performed HDX experiments for structural characterization of lyseninV88C/Y131C
(Figure 6A,B; top panel, blue). Based on the pattern of hydrogen–deuterium exchange, the introduction
of the double-cysteine mutation and the presence of a disulfide bridge did not alter the structural
dynamics of lysenin in aqueous solution. An overall view of the exchange pattern of lyseninV88C/Y131C
revealed no changes in the deuteration level along the entire protein sequence compared to lyseninWT
after 10 sec (Figure 6A; top panel, blue vs. black) and 20 min of exchange (Figure 6B; top panel,
blue vs. black). This similarity was also observed for lyseninV88C/Y131C in the presence of 10 mM
DTT, which broke the disulfide bond between cysteine residues at positions 88 and 131 and restored
lytic activity (Figure 6A,B; top panel, red vs. black). Precise analysis of differences in exchange
between lyseninWT and lyseninV88C/Y131C (both reduced and non-reduced form) confirmed that the
proteins shared similar structural stability in aqueous solution. Subtraction plots clearly indicated
that the dissimilarity of deuteration between corresponding peptides of the two proteins in relation
to lyseninWT did not exceed 5% for hydrogen–deuterium exchange reactions of 10 sec (Figure 6C;
lyseninV88C/Y131C in blue; lyseninV88C/Y131C with DTT in red) or 20 min (Figure 6D). Additionally,
the measurement of hydrogen–deuterium exchange at different times (10 sec, 1 min, 5 min, 20 min,
and 2 hours) enabled determination of the exchange kinetics in distinct peptides of lyseninWT and
lyseninV88C/Y131C. Based on this detailed analysis, we demonstrated the similar kinetics of deuterium
uptake for individual regions of lyseninWT and lyseninV88C/Y131C, both in the reduced and oxidized
forms, which further confirmed the similar structural dynamics of wild-type and mutated lysenin in
aqueous solution (Figure S5).
2.4. Changes in the Structural Dynamics of LyseninWT and LyseninV88C/Y131C in the Membrane-Bound Form
Conformational changes accompanying prepore and transmembrane pore creation may alter a
protein’s solvent accessibility or hydrogen bonding network, which are both reflected by changes
in the deuterium incorporation into protein. Comparison of the hydrogen–deuterium exchange
patterns of lyseninWT and lyseninV88C/Y131C bound to SM-containing membranes enabled us to map
the changes in lysenin’s conformational dynamics during pre-pore and pore formation. An overall
view of the exchange patterns of lyseninWT and lyseninV88C/Y131C interacting with SM-containing
liposomes, both with and without 10 mM DTT, indicated substantial reductions of deuterium uptake
after 20 min compared to the proteins in aqueous solution (Figure 7A–C; Figure S6). The HDX
patterns for lyseninV88C/Y131C with 10 mM DTT and lyseninWT bound to liposomes revealed that both
proteins had the same structural dynamics (Figure 7D). This clearly indicated that disulfide bridge
reduction in lyseninV88C/Y131C reinstated the structural dynamics to the state observed for lyseninWT,
with consequent full restoration of the lytic activity. Therefore, in further structural analyses, we used
a reduced form of lyseninV88C/Y131C as a model of pore-forming lysenin.
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Subtraction plots provided the best visualization of the differences in exchange between
corresponding peptides in lyseninV88C/Y131C bound to liposomes vs. in aqueous solution, with
or without DTT (Figure 7E). The subtraction plot clearly showed that lyseninV88C/Y181C, with or without
a reducing agent, revealed decreased deuteration (stabilization) along its entire sequence upon binding
to SM-containing liposomes as compared to in its soluble form. However, two regions in the N-terminal
domain of lyseninV88C/Y131C (both oxidized and reduced) demonstrated higher deuterium exchange
(destabilization) upon binding to liposomes than its soluble form. These regions included two common
peptides spanning positions 64–76 (strand β5), and one peptide spanning positions 114–118 (central
part of strand β8) (Figures 7E and 8D,E). We observed stronger stabilization (>60% difference between
soluble and liposome-bound forms) in lyseninV88C/Y131C with DTT (Figure 7E; red) compared to without
DTT (Figure 7E; blue). The largest differences in deuteration level concerned two segments of the
N-terminal domain of the two lyseninV88C/Y131C forms.
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Figure 8. Kinetics of hydrogen–deuterium exchange in selected lysenin peptides. Deuteration was
measured after exposure of lyseninV88C/Y131C in solution (black), and bound to liposomes with DTT
(red), bound to liposomes without DTT (blue) to D2O for 10 s, 1 min, 5 min, 20 min, 60 min, or 120 min
and is shown on a linear time scale. Plots show the patterns of hydrogen-deuterium exchang for lys nin
peptide 70–76 FEIGSVE (A); peptide 114–118 TRWQL (B); peptide 37–55 KITITKGMKNVNSETRTVT
(C); peptide 52–69 RT TATHSIGSTISTGDA (D); peptide 135–153 EVTPIG TQSIPQVITSRA (E); peptide
182–197 VSRKSWPAATLGHSKL (F); peptide 235–248 DQGTDNPKQRWAIN (G); peptide 282–293
YCLDKREDKWIL (H); peptide 16–27 VVAVWKEGYVYE (I); and peptide 262–272 MNKYFTRSGLC (J).
Each curve represents the average of three independent exchange experiments. Error bars represent S.D.
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One segment was localized in the region of amino acid positions 37–69, corresponding to strands
β3 andβ4, as well as the linker between strandβ4 and the tongue region that is clearly less exchangeable
in the reduced form of lyseninV88C/Y131C (Figures 7B,E and 8C,D; red). In consequence, in oxidized form
of lyseninV88C/Y131C, the peptide encompassing the tongue region (peptide at position 52–64) showed
exchange similar to that observed for the soluble form of lysenin (Figures 7A,E and 8D, blue). The other
segment, which showed a slightly less pronounced difference between the reduced and oxidized
form of lyseninV88C/Y131C, included strands β10 and β11 at positions 135–153 (Figures 7B,E and 8E,
red vs. blue). The C-terminal domain also exhibited significant stabilization upon binding to
liposomes, both with and without DTT (Figure 7E). Similar to the N-terminal domain, decrease in
the hydrogen–deuterium exchange was more pronounced in the reduced form of lyseninV88C/Y131C
than in its unreduced form. In the reduced form, the most reduced deuteration regions (exhibiting
deuteration of at least 50% lower compared to lysenin in solution) included positions 182–197, 235–248,
and 282–293 (Figures 7E and 8F,G,H; red).
We next compared the hydrogen–deuterium exchange pattern between liposome-bound
lyseninV88C/Y131C with vs. without DTT. This enabled mapping of the regions in lysenin that showed
changes in structural dynamics during the prepore-to-pore transition (Figure 9; Figures S6 and S7
blue vs. red). The pattern of hydrogen–deuterium exchange after 10 s of deuteration revealed very
low exchange for both the non-lytic and lytic forms of lysenin. The deuteration level did not exceed
30% along the majority of the lysenin sequence, with the clearest deviation identified for the tongue
(positions 52–69) in unreduced lyseninV88C/Y131C, which was relatively susceptible to deuteration
(Figure S7A; blue).
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Figure 9. Time-dependent hydrogen–deuterium exchange patterns of lyseninV88C/Y131C upon binding
to liposomes. (A,B) Changes in the hydrogen–deuterium exchange pattern of proteins upon binding
to liposomes for 10 sec (A) and 20 min (B) of exchange. Data were obtained by subtracting the
fraction of hydrogen–deuterium exchange of liposome-bound lyseninV88C/Y131C from lyseninV88C/Y131C
supplemented with 10 mM DTT after 10 s (A) or 20 min (B) of deuteration (red). Positive and
negative values on the axis, respectively, indicate regions that were destabilized and stabilized in
lyseninV88C/Y131C supplemented with 10 mM DTT upon binding to liposomes. Error bars were
calculated as the square root of the sum of variances of the subtracted numbers.
The vast majority of the both liposome-bound lysenin forms exhibited deuteration of ~20%
after 10 s of exchange reaction (Figure S7A). Despite the apparently similar structural dynamics,
the differential plot obtained after subtraction of the exchanged fraction of liposome-bound oxidized
lyseninV88C/Y131C from that of reduced lyseninV88C/Y131C revealed that lyseninV88C/Y131C in the presence
of DTT was slightly more protected to hydrogen–deuterium exchange compared with the nonlytic
form (Figure 9A).
After 20 min of exchange reaction, the deuteration level was significantly increased only for
lyseninV88C/Y131C without DTT, highlighting the native destabilization of this protein in its prepore
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state (Figure S7B; blue). The highest exchange (deuteration above 70%) was observed in the N-terminal
fragment including positions 52–69, and in the C-terminal region including positions 235–248 and
282–293 (Figure 8D,G,H; Figure S7B). We also identified fragments of both lysenin forms that showed
low deuteration levels (<30% deuteration), which included peptides encompassing amino acid positions
16–27, 119–181, and 262–272 (Figure S7B). These regions were strongly protected even after 2 h of
deuteration (Figure 8I,J), indicating that their stabilization occurred at the prepore formation stage
and was maintained until final pore formation. A differential plot provided better visualization of
the changes in lysenin’s structural stability accompanying prepore-to-pore conversion (Figure 9B).
Analysis revealed that lysenin generally underwent stabilization along its entire sequence during the
prepore-to-pore transition, although lysenin’s stabilization in the pore structure was only slightly
stronger compared with the prepore structure, with a difference not exceeding 30% of deuteration.
During prepore-to-pore conversion, we observed strong decrease of deuteration level of the lysenin
structure in only three regions, encompassing amino acid positions 37–69, 182–197, and 225–248
(Figure 9B). The weakest deuteration was observed for the peptide at position 52–69, corresponding
to the tongue region that forms the extended β-strand that is part of the transmembrane β-hairpin
(Figure 9B).
In summary, HDX-MS allowed determination of structural elements that were crucial for converting
lysenin from its soluble form to the pore structure. Using this method, we identified the changes in the
structural dynamics of these regions that occurred during two steps of pore formation: conversion of
the soluble form of lysenin into the prepore structure, and the prepore-to-pore transition. Formation
of the prepore structure was accompanied by different level of stabilization of the lysenin structure,
with the exception of the β5 strand that was more destabilized in the prepore than in the soluble form
(Figure 10A,B). Prepore-to-pore conversion involved progressing stabilization of the lysenin structure,
but these changes were less pronounced than in the case of prepore formation, excluding the region
between strands β3 and β5, and region in the C-terminal domain, encompassing strands β17–β22, that
were over-stabilized in the pore structure (Figure 10B). Interestingly, destabilization of the region at
amino acid positions 70–76 (β5 strand) remained unchanged during prepore-to-pore conversion, due
to the fact that this region protrudes on the other side after passing through the membrane (Figure 10B).
Overall, our results demonstrated that the structural dynamics of lysenin in the prepore state
significantly differed from the soluble monomer form, in both the N-terminal and C-terminal domains.
The data strongly indicated that the prepore formation forced changes in lysenin’s structural dynamics
that allowed conformational transition required for protein insertion into the lipid membrane and lytic
pore formation.
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Figure 10. Simplified presentation of structural elements of lysenin that were stabilized and destabilized
at diff rent steps of pore fo mation. (A,B) HDX-MS results for 20 min of deuterium exchange reaction of
soluble and liposome-bound lyseninV88C/Y131C with or without DTT, overlaid on the lysenin struct re
(PDB:3ZXG) (A), and a ong the lysenin s quence (B). (A) In the wa er-soluble form structure, red
indicates deuterium exchange in the range of 80–100%, yellow indicates 40–80%, and blue indicates <40%.
In the prepore form structure, turquoise indicates peptides that were more stable in liposome-bound
lyseninV88C/Y131C (prepore form) than in its soluble form, but less stable than in liposome-bound
lyseninV88C/Y131C supplemented with DTT (pore); blue indicates peptides that were more stable in both
the prepore and pore forms than in the soluble form; green indicates regions that were unchanged in
the prepore form compared to the soluble form; red indicates peptides that were more destabilized in
both the prepore and pore forms than in the soluble form; and grey indicates regions not covered by
the data. In the pore form structure, blue represents structural elements that were more stable in the
pore than in the soluble form of lysenin; green indicates regions that were unchanged in the pore form
compared to the soluble form; and red indicates structural elements that were more destabilized in the
pore form than in soluble lysenin. The square illustrates the results overlaid on the protomer of the
lysenin pore structure (PDB: 5EC5). (B) Differences in the stabilization and destabilization of structural
elements between the soluble and prepore forms (upper diagram) and between the soluble and pore
forms (middle diagram). Color legend is the same as in (A prepore form). The lower diagram shows
differences in the stabilization and destabilization between the prepore and pore forms. Blue indicates
structural elements that were more stable in the pore than in the prepore form; and magenta indicates
structural elements that were unchanged during the prepore-to-pore transition.
3. Discussion
The interaction of lysenin with SM-containing membranes forces structural changes within the
toxin molecule, leading to transmembrane pore formation. Lytic pore formation is a complex process
that involves binding of lysenin’s monomeric form to the SM-containing membrane, oligomerization
on the plasma membrane surface, and insertion of lysenin into the lipid membrane. In a previously
proposed model, lytic pore formation is initiated by the binding of lysenin to a SM-enriched lipid
membrane via the C-terminal domain of the toxin molecule. The lysenin molecule concentration at the
membrane surface promotes interactions between neighboring monomers, leading to the formation of
arc-shape oligomers that eventually grow into complete nonameric ring-shaped prepores [22]. It has
not previously been shown that prepore formation is accompanied by structural changes in the lysenin
molecule, although conformational changes during the monomer-to-prepore transition have been
observed for other members of the aerolysin family, including aerolysin and epsilon toxin [29–31].
Finally, significant structural rearrangement within lysenin’s N-terminal domain enables insertion of
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the protein into the lipid membrane, and formation of a β-barrel transmembrane pore. Prior analyses of
the crystal and cryo-EM structures of the lysenin pore clearly reveal the structural rearrangement that
occurs during the transition of the soluble monomer structure to the membrane-inserted oligomeric
state [8,22]. Conformational changes accompanying lytic pore formation lead to reorganization of
a region of the N-terminal domain including three β strands (β4, β5, and β6), which consequently
forces extension of the β3 and β7 strands and a single 310 α-helix, promoting their assembly into
the twisted β-hairpin. This rearrangement results in downward rotation of the N-terminal domain
and a bend in the middle of the structurally intact region of the N-terminal domain (collar), allowing
insertion of the twisted β-hairpins of adjacent monomers into the membrane and formation of the
β-barrel. Although analysis of the lysenin pore structure has provided new insights into the final
membrane-inserted state, structural characterization of the intermediate steps along the pore-formation
pathway is required to derive the complete molecular mechanism.
In our present study, we endeavored to gain information about the dynamics of conformational
changes occurring during prepore and pore formation. To this end, we characterized the interaction of
the V88C/Y131C lysenin mutant with lipid membranes and determined its structural dynamics in both
the water-soluble and membrane-bound forms. This double mutation enables the creation of a disulfide
bridge between cysteine residues at positions 88 and 131, which prevents insertion loop displacement
and consequently abolishes pore formation. On the other hand, this disulfide bond does not affect
lysenin’s ability to form nonameric oligomers. Reduction of the disulfide bond leads to disengagement
and unfolding of the insertion loop, which completely restores pore-forming activity to the level
observed for lyseninWT. As previously shown for another pore-forming protein, perfringolysin O,
the introduction of single point mutations induces local changes in the protein structure and may
also cause global changes in the protein structure without influencing the secondary structure [25,32].
It has also been shown that the introduction of a point mutation outside of the area involved in
membrane binding can alter the interaction between the receptor-binding motif (domain) and the lipid
bilayer, indicating both structural and functional coupling of distant and spatially separated domains
of PFO [33]. These prior findings indicated a need to verify the binding properties of lyseninV88C/Y131C.
Extensive analysis of lysenin’s interaction with the lipid bilayer revealed that the double-cysteine
mutation and the creation of a cysteine bridge between strands β6 and β10 did not affect lysenin’s
recognition and initial binding to SM or oligomer formation. However, subtle differences in the
stability of this interaction were detectable depending on the redox state of the V88C and Y131C
residues. The decreased surface pressure of the lipid monolayer in the presence of the oxidized form of
lyseninV88C/Y131C, the increased dissociation of this protein upon binding to SM-containing liposomes,
less contrasting oligomers in ultrastructural analysis, and higher susceptibility to proteolysis indicated
weaker anchoring of lysenin oligomers in the lipid membrane, thus confirming impairment of lysenin’s
insertion into the lipid membrane in the prepore state. Based on these properties of lyseninV88C/Y131C,
we decided to use the soluble form of this protein as a model for studying the starting structure during
pore formation, and to use the liposome-bound lyseninV88C/Y131C under different redox conditions as
model to study the prepore and pore forms.
Previous data have revealed that the flexibility of two regions: the random coil region (V157–E167)
connecting the C-terminal domain to the structurally intact region of the N-terminal domain (collar)
and the tongue region (M44–G67) play crucial roles in the transition from the soluble monomer to the
membrane-inserted state [22]. The high dynamics of the linker between the N-terminal and C-terminal
domains allows lysenin to collapse toward the lipid membrane and the flexibility of the tongue enables
formation of the β-hairpin that incorporates into the lipid bilayer. Our present HDX results confirmed
that both regions were highly dynamic in the soluble form of lysenin. However, both were strongly
stabilized upon incorporation into the lipid bilayer and pore formation (Figure 10). Interestingly,
the linker between the N-terminal and C-terminal domains was strongly stabilized already in the
prepore state, and the stabilization was similar as in the pore. In contrast, the tongue region showed a
similar (region between strands β4 and β5) or slightly reduced (region between strands β3 and β4)
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flexibility in the prepore state compared to the soluble monomer of lysenin. We also demonstrated
that prepore formation was accompanied by stabilization of β strands embedded in the collar region,
and exposure of the hydrophobic β5 strand to the solvent, which ultimately created the transmembrane
β-hairpin and inserted it into the lipid bilayer. These findings indicated that the gradual decrease in
flexibility of the tongue fragment, and the stability of the β-strand network in the collar region, play
crucial roles in the prepore-to-pore transition.
In the previously described prepore model, the N-terminal twisted β-sheet remains structurally
intact relative to lysenin in its soluble state. Therefore, the β2 strand is faced toward the insertion
loop of the neighboring lysenin molecule and interacts and arranges itself parallel to the β10
strand of the adjacent monomer only upon unwinding of the tongue and tilting by 45◦ from the
collar [22]. The network of interactions between amino acid residues maintains the correct dynamics
and conformation of lysenin that are required for the structural rearrangement involved in lytic
pore formation.
Our present findings support the possibility that subtle intramolecular rearrangements in lysenin
occur at prepore formation step, which ultimately facilitate membrane insertion and pore formation.
Despite the salt bridges are not dominant factors that governs lysenin’s stability in the soluble
monomeric form, they are one type of interaction crucial for structural rearrangement of monomer
during pore formation (Figure 11A–E) [8].
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The formation of intermolecular salt bridges between adjacent monomers during oligomerization
is the mechanism controlling the transition of prepore to pore in perfringolysin O and may commonly
occur among pore-forming proteins [34].
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Electrostatic interactions are also important for maintaining contact between adjacent monomers
and the stability of the β-barrel pore (Figure 11F) [22]. Our results suggested that stiffening of the
N-terminal twisted β-sheet formed by β2, β8, β9, β10, and β11 may force the breaking of salt bridges
between the α-helix and tongue (R52–E92), β8 strand and tongue (H58–D121), and β5 and β10 strands
(H81–E135), thus leading to slight stabilization of the insertion loop and consequently exposing the β5
strand to solvent and increasing its conformational dynamics (Figures 8A and 11). This orientation is
energetically unfavorable; therefore, to decrease the energy state, the insertion loop must be displaced,
thus allowing unfolding of the β-hairpin and formation of the β-barrel pore structure.
Based on our present findings and previous work, we also conclude that the interaction of lysenin
with an SM-containing membrane in the prepore state moderately affect the structural dynamics of the
C-terminal domain, including the regions that interact with the phosphocholine head group of SM,
including peptide 180–192 (K185), peptide 225–233 (S227, Q229, Y233), and peptide 282–293 (Y282) [9].
Surprisingly, the prepore-to-pore transition was accompanied by strong stabilization of the C-terminal
part of lysenin, even at regions that are not critical for SM binding. This may be explained by the
structural rearrangement within the N-terminal domain of lysenin during pore formation, which forces
the proper orientation and stability of the lysenin pore in the lipid membrane, including stabilization of
the C-terminal domain of lysenin. This observation indicates that the receptor-binding domain’s role is
not limited only to the recognition of targets on cell membranes but is also crucial for stabilizing the
oligomeric complex of the lysenin in the prepore form and the formation of functional pore structures.
It can be assumed that initial electrostatic interaction between C-terminal domain of lysenin and POC
forces changes in the structural dynamics of lysenin, which lead to stabilization of structural elements
in the N-terminal domain, including the region responsible for the interaction of lysenin with the SM
acyl chain tail (β2 strand containing Y24 and Y26). Stabilization of this region was found already at
the prepore state and is maintained also in the pore form. Similar effect is observed for β10 strand
that interacts with β2 of adjacent monomer during pore formation upon tilting from the collar and
unwinding of the tongue [22]. Stabilization of these two elements at the prepore stage may indicate
that initial interaction of lysenin with the lipid membrane induces dynamic changes first in the regions
responsible for assembly of oligomeric complex, and only then in the regions that participate in the
insertion of lysenin into the membrane. Thus, we suggest that the initial interaction of β2 and β10 of
adjacent monomers takes place even before unwinding of the tongue. However, despite the fact that a
lot of detailed information on the structural dynamics of lysenin at various stages of pore formation has
been obtained, extensive research is still required to fully understand the mechanism of pore formation.
The above-presented results demonstrate that HDX-MS is an excellent technique that provides
valuable data regarding the structural dynamics of proteins at different steps of their interactions
with lipid membranes. Our results obtained using this method show that binding to SM-containing
membranes caused changes in the structural dynamics of lysenin, as early as in the prepore state.
At this stage, interaction between adjacent monomers induced conformational stabilization of
lysenin, which was initiated at the membrane-binding site in the C-terminal domain of lysenin and was
transmitted via the N-terminal twisted β-sheet to the region forming the transmembrane domain of the
pore (Figure 12). Structural stabilization of these regions forced a structural rearrangement within the
PFM, which was accompanied by stabilization of insertion loop and was required for transmembrane
lytic pore formation.
Overall, our present results demonstrated that the HDX-MS technique perfectly complements
structural studies based on crystallography and high-resolution microscopy, bringing us closer to a full
understanding of the molecular mechanism of pore formation by lysenin.
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Figure 12. Schematic representation of the differences in structural stability between the soluble,
prepore and pore forms of lysenin. Blue regions superimposed on the monomeric crystallographic
structure of lysenin in the “prepore” indicate peptides that were more and less stable in the lysenin
prepore form than in its soluble form. Grey regions indicate peptides that were unchanged in the
prepore form compared to the soluble form. In the “pore” structure: blue regions indicate regions that
were more stable in the lysenin pore form than its prepore form; grey regions indicate peptides that
were unchanged in the pore form compared to the prepore form. In the square the results overlaid on
the protomer of the lysenin pore structure are shown.
4. Materials and Methods
4.1. Expression and Purification of Recombinant Proteins
The plasmids expressing lyseninWT and lyseninV88C/Y131C with a HIS tag at the N
terminus were generated from the pGEX4T-lysenin WT template, constructed as previously
described [17]. The V88C/Y131C substitution in the lysenin sequence was generated by site-directed
mutagenesis using two primer pairs: 5′-CATGAAGAATCCCAATGTAGCATGACGGAAAC-3′
and 5′-GTTTCCGTCATGCTACATTGGGATTCTTCATG-3′ to introduce the V88C mutation,
and 5′-GATATTGAATACATGTGTTTGATTGATGAAGTC-3′ and 5′-GACTTCATCAATCAAACA
CATGTATTCAATATC-3′ for the Y131C substitution. The cDNA fragments encoding the two
proteins were amplified by PCR, and subcloned into the pET28a(+) vector (Novagen, Madison,
USA) using BamHI/HindIII restriction sites. The recombinant vectors pET28a-lyseninWT and
pET28-lyseninV88C/Y131C were transformed into the E. coli BL21(DE3) and SHuﬄe T7 Express
strains, respectively. The produced proteins (Figure S6) were purified on a Ni Sepharose 6 Fast Flow
column (GE Healthcare, Munich, Germany) and dialyzed against 30 mM Tris buffer (pH 7.5) containing
150 mM NaCl. Finally, the collected samples were mixed with 10% (v/v) glycerol, frozen in liquid
nitrogen, and stored at −80 ◦C.
4.2. Protein-Lipid Overlay Assay
To test the specificity of lipid recognition by lyseninV88C/Y131C, we spotted nitrocellulose
membranes with 1 µL of lipid samples containing various amounts (5–50 pmol) of 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC; Avanti), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC;
Avanti), cholesterol (Sigma-Aldrich, Munich, Germany), or bovine brain SM (Sigma-Aldrich, Munich,
Germany) in a chloroform:methanol:water mixture (1:1:0.3, v/v). The membranes were blocked for
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1 h at 20 ◦C with 1% gelatin and 1% polyvinylpyrrolidone in Tris-buffered saline containing 0.03%
Tween-20 (TBST) and then incubated for 2 h with 100 nM lyseninWT or lyseninV88C/Y131C and processed
as previously described [14].
4.3. Surface Plasmon Resonance
We examined the interaction of lyseninWT and lyseninV88C/Y131C with large unilamellar vesicles
(LUVs) using a BIAcore 3000 instrument (GE Healthcare, Munich, Germany) equipped with an L1 chip.
LUVs composed of SM/DOPC/cholesterol (molar ratio 1:2:1) were prepared as previously described,
yielding a final lipid concentration of 1 mM [17]. The liposomes were deposited onto the L1 chip
surface, at a flow rate of 1 µL/min for 10 min, using an amount that yielded 7000 resonance units
(RU). Measurements were conducted using 1 µM protein at a flow rate of 5 µL/min for 300 s. Then,
the dissociation of the deposited protein was followed for an additional 300 s.
4.4. Surface Pressure Measurement
These experiments were performed using a NIMA Technologyn tensiometer model PS3 (Coventry,
UK) at 20 ± 1 ◦C in darkness under an argon atmosphere, as previously described [13]. The water
sub-phase was buffered with 30 mM Tris-HCl (pH 7.5). To measure the surface pressure of mixed
lipid monomolecular layers, a lipid monolayer comprising SM/DOPC/cholesterol (molar ratio 1:2:1)
or DOPC/cholesterol (molar ratio 2:1) was deposited at the argon–water interface from a chloroform
solution. A 40 µM final concentration of lyseninWT or lyseninV88C/Y131C (with or without 10 mM DTT)
was injected into the 12 mL of buffer sub-phase.
4.5. Oligomerization Assay
To prepare small unilamellar vesicles (SUVs) composed of SM/DOPC/cholesterol (1:2:1 molar ratio,
1 mM total phospholipid concentration), we resuspended the lipid film in buffer containing 30 mM Tris
and 150 mM NaCl (pH 7.5). This liposome suspension was vortexed for 5 min and then subjected to six
freeze-thaw cycles, and sonication (30 min, 0.3 cycle, amplitude 33%). After centrifugation at 10,000× g
(30 min, 4 ◦C), the pelleted SUVs were resuspended in buffer containing 30 mM Tris and 150 mM NaCl
(pH 7.5), and incubated with 1 µM lyseninWT or lyseninV88C/Y131C (with or without 10 mM DTT) for
30 min at 25 ◦C and 37 ◦C. The samples were then pelleted by centrifugation at 10,000× g (30 min),
suspended in 20 µL of SDS loading buffer (40% glycerol (v/v), 25% SDS (w/v), and 0.1% bromophenol
blue (w/v)), and analyzed by SDS-PAGE.
The oligomeric complexes of lysenin were then analyzed for their susceptibility to proteolysis.
The samples of proteins bound to liposomes were suspended in buffer containing 30 mM Tris and
150 mM NaCl (pH 7.5) and supplemented with trypsin (trypsin:protein ratio 1:20, w/w; Promega).
After incubation for 2 hours at 37 ◦C, the samples were diluted with SDS loading buffer and analyzed
by SDS-PAGE.
4.6. Measurement of Intrinsic Protein Fluorescence
To determine the intrinsic protein fluorescence, we measured the tryptophan emission spectra
of lyseninWT and lyseninV88C/Y131C, both in solution and bound to liposomes. SUV preparation and
lysenin binding to lipid vesicles were performed as described above. Tryptophan emission was excited
at 280 nm, and fluorescence emission was recorded from 300 to 400 nm at 1 nm/s. All measurements
were made using a JASCO FP 6500 spectrofluorimeter at 25 ◦C. The spectral band widths were 3 nm
for both excitation and emission.
4.7. Electron Microscopy
Ultrastructural studies of lysenin oligomeric complexes were performed as described by
Kwiatkowska et al. [14], with some modifications. To prepare multilamellar lipid vesicles (MLVs),
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the lipid film (composed of SM/DOPC/cholesterol in a 1:2:1 molar ratio) was suspended in buffer
containing 30 mM Tris and 150 mM NaCl (pH 7.5), vortexed, and sonicated for 2 min at 4 ◦C (30 min,
0.3 cycle, amplitude 33%). After centrifugation at 15,000× g (15 min, 4 ◦C), the liposomes were
resuspended in buffer containing 30 mM Tris and 150 mM NaCl (pH 7.5) and incubated for 30 min
at 20 ◦C with 7 µM lyseninWT or lyseninV88C/Y131C, with or without 10 mM DTT. After incubation,
the liposomes were fixed with 1% glutaraldehyde in PBS for 20 min at 20 ◦C and transferred onto
poly-L-lysine-coated and formvar/carbon-treated grids for 20 min. Finally, the samples were washed
twice with PBS and once with water, counterstained with 2% uranyl acetate, and examined under a
JEM-1200EX (JEOL) microscope.
4.8. Pore-Forming Activity
SUVs composed of SM/DOPC/cholesterol (1:2:1 molar ratio) were prepared as described above, in
the presence of 50 µM 6-carboxyfluorescein (Sigma, Munich, Germany). These SUVs were pelleted,
resuspended in buffer containing 30 mM Tris and 150 mM NaCl (pH 7.5), and incubated with 1 µM
lyseninWT or lyseninV88C/Y131C with or without 10 mM DTT. The suspension was incubated for 30 min
at 20 ◦C, and then centrifuged. The level of released carboxyfluorescein in the supernatant was
measured using a Jasco FP 6500 spectrofluorometer at an excitation/emission of 492/517 nm. The results
were expressed as the percentage of maximum carboxyfluorescein release from SUVs, as triggered by
addition of 0.1% Triton X-100.
4.9. Hemolytic Activity
The hemolytic activity of lyseninWT and lyseninV88C/Y131C was measured as previously
described [14]. Briefly, serial protein dilutions (up to 1 µM) were incubated for 45 min at 20 ◦C
and 37 ◦C, with 7 × 107 sheep red blood cells (RBCs), with or without 10 mM DTT. Then the samples
were centrifuged at 200× g (5 min, 4 ◦C), and the level of hemoglobin released from RBCs was
estimated by measurement of the supernatant’s absorbance at 405 nm using a NanoDrop 2000c
Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The results were expressed as the
percentage of maximal hemolysis (100%), obtained by osmotic lysis of RBCs with water.
4.10. Hydrogen–Deuterium Exchange Measurements
Samples for hydrogen–deuterium exchange were prepared following a previously described
procedure, with some modifications [24,25]. Briefly, lipid-bound samples were prepared by incubation
of 4 µM lyseninWT and lyseninV88C/Y131C (with or without 10 mM DTT) with 2 mM SUVs composed
of SM/DOPC/cholesterol (molar ratio 1:2:1) at room temperature for 30 min. Then, the samples
were centrifuged at 10,000× g (10 min, 4 ◦C), and the pellets were resuspended in 30 mM Tris with
150 mM NaCl (pH 7.5) supplemented with 2% n-dodecyl-β-D-maltoside (DDM) and incubated at room
temperature for 1 h with shaking. Next, the samples were again centrifuged at 10,000× g (10 min, 4 ◦C),
and the supernatant containing extracted oligomers was subjected to HDX-MS.
The HDX-MS measurements were compared between lyseninV88C/Y131C and lyseninWT, without
liposome binding (aqueous solution) and upon binding to liposomes (extracted oligomers).
The hydrogen–deuterium exchange reaction was initiated by adding 5 µL protein sample to 45 µL D2O
Reaction buffer (30 mM Tris and 150 mM NaCl, pH 7.5). The reaction was carried out for the required
time period (10 s, 1 min, 5 min, 20 min, 120 min, or 24 h) and was quenched by adding the reaction
mixture to 10 µL pre-chilled D2O stopping buffer (2 M glycine and 150 mM NaCl, pH 2.4). Finally,
the samples were injected onto an immobilized pepsin column (Poroszyme; ABI), and the obtained
peptides were further separated using the nanoACQUITY ultra-performance liquid chromatography
(UPLC) system, followed by mass measurements on the SYNAPT G2 HDMS mass spectrometer
(Waters, Milford, MA, USA). Peptide identification was based on a list of peptic peptides obtained for
a non-deuterated sample using ProteinLynx Global Server software (Waters, Milford, MA, USA), as
previously described [25]. HDX data analysis was performed using the DynamX 2.0 program (Waters,
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Milford, MA, USA). All measurements were repeated in triplicate. All controls were performed,
including a back-exchange control and a carry-over effect control.
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lyseninWT and lyseninV88C/Y131C, Figure S5. Effects of the V88C/Y131C mutation on the deuterium uptake of
lysenin in aqueous solution, Figure S6. The overlay of HDX results of peptides on the crystal structures of
lysenin, Figure S7. Time-dependent hydrogen–deuterium exchange patterns of lyseninV88C/Y131C upon binding to
liposomes, Figure S8. Amino acid sequence of recombinant lysenin.
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